PoleStar® N30 Surgical MRI for Neurosurgery Designed to Help Optimize Tumor Resection Procedures
MINNEAPOLIS–(HSMN NewsFeed)–Medtronic (NYSE: MDT ) today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions. More »
Offering Surgeons the Next Generation of Occipitocervical Upper-Thoracic Fixation
MEMPHIS, Tenn.–(HSMN NewsFeed)–Medtronic, Inc. (NYSE: MDT ) today announced the U.S. launch of the VERTEX SELECT® Reconstruction System.
When a patient has a spinal condition that requires fusion or a procedure that must be performed from the back of the spine, also known as a posterior approach, the VERTEX SELECT® Reconstruction System contains implants and an instrument set for performing this surgical procedure. More »
MEMPHIS, TENN.– December 18, 2009 – Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the SOVEREIGN™ Spinal System. More »
SAN FRANCISCO – Nov. 11, 2009 – Medtronic, Inc. (NYSE: MDT) today announced the full U.S. market release of MASTERGRAFT® Strip – a new, highly flexible ceramic scaffold intended for use in combination with a patient’s own bone for fusing multiple levels of the posterolateral spine.
The full market release was announced today at the 24th Annual meeting of the North American Spine Society (NASS) in San Francisco. MASTERGRAFT Strip was cleared by the U.S. Food and Drug Administration (FDA) earlier this year and has been clinically evaluated by surgeons for a variety of bone grafting procedures with outstanding intraoperative performance. More »
| Nuvasive, Inc. | 32.77 | ||
| Zimmer Holdings, | 52.99 | ||
| Alphatec Holdings | 4.23 | ||
| Smith & Nephew Sn | 43.62 | ||
| Trans1 Inc. | 2.49 | ||
| Medtronic Inc. Co | 36.97 | ||
| Synthes | 119.80 | ||
| Rti Biologics, In | 2.89 | ||
| Johnson & Johnson | 58.09 | ||
| Orthofix Internat | 30.28 | ||
| Covidien Plc. Ord | 37.32 | ||
| Orthovita, Inc. | 1.85 |
Archive for Publications »
